ANTHEM, INC.

(ANTM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Anthem to Hold Conference Call and Webcast to Discuss Fourth Quarter Results on January 26, 2022

01/12/2022 | 04:08pm EDT

Anthem, Inc. (NYSE: ANTM) will release fourth quarter 2021 financial results on January 26, 2022, at 6:00 a.m. Eastern Standard Time (“EST”). Management will review these results and its outlook during a conference call at 8:30 a.m. EST that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:

888-947-9963 (Domestic)

800-570-8796 (Domestic Replay)

312-470-0178 (International)

203-369-3293 (International Replay)

The access code for the call is 3972058. There is no access code for the replay. The replay will be available from 11:30 a.m. EST on January 26, 2022 until the end of the day on February 25, 2022. The call will also be available through a live webcast at www.antheminc.com under the “Investors” link. A webcast replay will be available following the call.

About Anthem, Inc.

Anthem is a leading health company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 117 million people, including more than 45 million within its family of health plans. Delivering health beyond healthcare, Anthem is expanding from being a partner in health benefits to a lifetime, trusted health partner. For more information, please visit www.antheminc.com or follow @AnthemInc on Twitter.


© Business Wire 2022
All news about ANTHEM, INC.
05/11TRANSCRIPT : Anthem, Inc. Presents at Bank of America 2022 Healthcare Conference, May-11-2..
CI
05/05Anthem, Inc. Completes Acquisition of Integra Managed Care
BU
05/05Anthem, Inc. completed the acquisition of Integra MLTC, Inc. from Personal-Touch Home C..
CI
05/04Mizuho Securities Adjusts Anthem's Price Target to $545 From $510, Reiterates Buy Ratin..
MT
04/29ANTHEM, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
04/28AM Best Assigns Issue Credit Ratings to Anthem, Inc.'s New Senior Unsecured Notes
AQ
04/26Anthem Announces Appearance at Upcoming Conference
BU
04/25UnitedHealth to sell Change Healthcare's claims business for $2.2 bln
RE
04/25RBC Raises Price Target on Anthem to $544 From $452, Calls Q1 Beat 'Solid,' Guidance Ra..
MT
04/22ANTHEM : REPORTS FIRST QUARTER 2022 RESULTS, REFLECTING STRONG MOMENTUM ACROSS ALL DIVISIO..
PU
More news
Analyst Recommendations on ANTHEM, INC.
More recommendations
Financials (USD)
Sales 2022 153 B - -
Net income 2022 6 440 M - -
Net Debt 2022 15 879 M - -
P/E ratio 2022 18,7x
Yield 2022 1,00%
Capitalization 119 B 119 B -
EV / Sales 2022 0,88x
EV / Sales 2023 0,81x
Nbr of Employees 98 200
Free-Float 99,4%
Chart ANTHEM, INC.
Duration : Period :
Anthem, Inc. Technical Analysis Chart | ANTM | US0367521038 | MarketScreener
Technical analysis trends ANTHEM, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 22
Last Close Price 493,59 $
Average target price 555,33 $
Spread / Average Target 12,5%
EPS Revisions
Managers and Directors
Gail Koziara Boudreaux President, Chief Executive Officer & Director
John Edward Gallina Chief Financial Officer & Executive Vice President
Elizabeth E. Tallett Independent Chairman
Dustin Wilcox VP & Chief Information Security Officer
Gloria M. McCarthy Chief Administrative Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
ANTHEM, INC.6.48%117 276
UNITEDHEALTH GROUP-3.33%455 388
CIGNA CORPORATION12.87%82 234
HUMANA INC.-5.38%55 517
CENTENE CORPORATION-0.10%48 148
MOLINA HEALTHCARE, INC.-6.98%17 361